Results 121 to 130 of about 15,380 (223)

FOLFIRINOX: Desert, Oasis, or Mirage? [PDF]

Annals of Surgical Oncology, 2014
openaire   +2 more sources

An Analysis of Pancreatic Cancer [PDF]

, 2015
poster abstractThe pancreas is extremely important in various enzymatic activities, such as the production of numerous enzymes such as insulin. Pancreatic Cancer is an extremely deadly disease, which 40,000 people of the 46,000 diagnosed each year fail ...
Wagle, Pragat
core  

FOLFIRINOX in pancreatic cancer

Annals of Oncology, 2017
Esther Una Cidon, Pilar Alonso
openaire   +1 more source

Folfirinox Regimen [PDF]

, 2020
openaire   +1 more source

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer

JAMA Oncology
ImportancePancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant tumor, and durable disease control is rare with the current standard of care, even for patients who undergo surgical resection.ObjectiveTo assess whether neoadjuvant modified 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan (mFOLFIRINOX) leads to early control of ...
Cecchini, Michael, Salem, Ronald R., Robert, Marie, Czerniak, Suzanne, Blaha, Ondrej, Zelterman, Daniel, Rajaei, Moein, Townsend, Jeffrey P., Cai, Guoping, Chowdhury, Sumedha, Yugawa, Deanne, Tseng, Robert, Mejia Arbelaez, Carlos, Jiao, Jingjing, Shroyer, Kenneth, Thumar, Jaykumar, Kortmansky, Jeremy, Zaheer, Wajih, Fischbach, Neal, Persico, Justin, Stein, Stacey, Khan, Sajid A., Cha, Charles, Billingsley, Kevin G., Kunstman, John W., Johung, Kimberly L., Wiess, Christina, Muzumdar, Mandar D., Spickard, Erik, Aushev, Vasily N., Laliotis, George, Jurdi, Adham, Liu, Minetta C., Escobar-Hoyos, Luisa, Lacy, Jill   +34 more
openaire   +2 more sources

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer

The Journal of Liquid Biopsy
Background: Novel biomarkers, such as plasma microRNAs (miRs), are needed to help guide clinical decision-making for the type of chemotherapy to use in patients with advanced pancreatic ductal adenocarcinoma (PDAC).
Lenka N.C. Boyd, Mahsoem Ali, Jisce R. Puik, Annalisa Comandatore, Laura Ginocchi, Laura L. Meijer, Rutger-Jan Swijnenburg, Roberta Tartarini, Tessa Y.S. Le Large, Luca Morelli, Ingrid Garajova, Marc G. Besselink, Andrea Mambrini, Johanna W. Wilmink, Adam E. Frampton, Hanneke W.M. van Laarhoven, Elisa Giovannetti, Geert Kazemier   +17 more
doaj   +1 more source

Modified FOLFIRINOX Regimen [PDF]

, 2020
openaire   +1 more source

Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients

Cancer Treatment and Research Communications
Background: While fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) offers a survival advantage in advanced pancreatic adenocarcinoma (PAC) compared to gemcitabine, gemcitabine-oxaliplatin, and gemcitabine-nab-paclitaxel, the outcome of ...
Hassan Abdelilah Tafenzi, Youssef Ait Takniouine, Ismail Essadi, Rhizlane Belbaraka   +3 more
doaj   +1 more source

Safety profile of modified FOLFIRINOX

Annals of Oncology, 2015
Masaki Sakuma, Hiroko Hayashi, Takuji Iwashita, Shinya Uemura, Mitsuru Okuno, Akio Suzuki, Masahito Shimizu, Yoshinori Ito   +7 more
openaire   +1 more source

Pancreatic Cancer and FOLFIRINOX

Annals of Surgery, 2018
Neoptolemos, John P, Halloran, Christopher M, Ghaneh, Paula, Kleeff, Jorg   +3 more
openaire   +2 more sources